An Observational Study to Assess the Effectiveness and Safety of Cemiplimab Based Regimen in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe (CEMI-LUNG)

Status: Recruiting
Location: See all (48) locations...
Intervention Type: Drug
Study Type: Observational
SUMMARY

This study is focused on patients with non-small cell lung cancer (NSCLC) and have been prescribed a cemiplimab (Libtayo®) based treatment regimen under standard care. The goal of this study is to learn more about the use, benefits, and safety of cemiplimab based treatment regimens in participants with NSCLC.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• At least 18 years of age at the time of cemiplimab treatment initiation

• Has been diagnosed with histologically or cytologically documented squamous or non-squamous NSCLC

• Prescribed a cemiplimab-based regimen as part of routine clinical practice as determined by the treating physician per standard of care and in accordance with the Summary of Product Characteristics (SmPC).

• Can understand and complete the study-related questionnaires

• Must be legally capable of providing written consent for participation in the study and have signed informed consent prior to any study activities

Locations
Other Locations
Austria
Klinikum Klagenfurt
RECRUITING
Klagenfurt
Salzburger Landeskliniken (SALK)
RECRUITING
Salzburg
France
Centre Hospitalier Universitaire Angers
RECRUITING
Angers
Sainte Catherine Institut du Cancer Avignon Provence
RECRUITING
Avignon
Center Hospitalier Universitaire (CHU) of Clermont
RECRUITING
Clermont-ferrand
Centre Hospitalier - Le mans
RECRUITING
Le Mans
APHM - Hopital Nord
RECRUITING
Marseille
Le Groupe Hospitalier de la Region de Mulhouse et Sud Alsace, Emile Muller Hospital
RECRUITING
Mulhouse
Hopital Tenon
RECRUITING
Paris
Centre Hospitalier Universitaire (CHU) de Poitiers
RECRUITING
Poitiers
Hopitaux Universitaires de Strasbourg
RECRUITING
Strasbourg
Germany
Gemeinschaftskrankenhaus Havelhoehe
RECRUITING
Berlin
Klinikum Chemnitz gGmbH
WITHDRAWN
Chemnitz
Gesellschaft fur Onkologische Studien Dortmund mbH (Gefos)
RECRUITING
Dortmund
Franziskus Hospital Harderberg
RECRUITING
Georgsmarienhütte
Krankenhaus Martha-Maria Halle-Doelau gGmbH
RECRUITING
Halle
Klinikum Konstanz
RECRUITING
Konstanz
Pneumologische Praxis PD Dr. Med Christian Gessner
RECRUITING
Leipzig
Marienhaus Klinikum Mainz
WITHDRAWN
Mainz
Staedtisches Klinikum Muenchen Bogenhausen
RECRUITING
München
St. Franziskus Hospital Münster
RECRUITING
Münster
Nuremberg Hospital, Campus North
RECRUITING
Nuremberg
Agaplesion Diakonieklinikum Rotenburg
RECRUITING
Rotenburg (wümme)
Haematologisch Onkologische Schwerpunktpraxis - Troisdorf
RECRUITING
Troisdorf
MedFISMO
WITHDRAWN
Weinsberg
Italy
AO Universitaria Policlinico Vittorio Emanuele
RECRUITING
Catania
AOU Careggi
RECRUITING
Florence
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITING
Milan
Humanitas Istituto Clinico Catanese
RECRUITING
Misterbianco
Azienda Ospedaliero-Universitaria di Modena
RECRUITING
Modena
AORN dei Colli
RECRUITING
Napoli
Istituto Nazionale Tumori IRCCS Fondazione G Pascale
RECRUITING
Napoli
San Luigi Gonzaga University Hospital
RECRUITING
Orbassano
Fondazione IRCCS Policlinico San Matteo
RECRUITING
Pavia
Ospedale Di Cisanello Azienda Ospedaliero Universitaria
RECRUITING
Pisa
IRCCS Humanitas Research Hospital
RECRUITING
Rozzano
Azienda Sanitaria Locale (ASL) Taranto
RECRUITING
Taranto
Spain
Hospital Torrecardenas
RECRUITING
Almería
Consorcio Hospitalario Provincial de Castellon
RECRUITING
Castellon
Complejo Hospitalario Universitario de Ferrol - Hospital Naval
RECRUITING
Ferrol
University Hospital of Jaen
RECRUITING
Jaén
Hospital Universitario De Jerez
RECRUITING
Jerez De La Frontera
Hospital Arnau de Vilanova
RECRUITING
Lleida
Hospital Universitario Virgen De La Victoria Malaga
RECRUITING
Málaga
Parc Tauli Sabadell Hospital Universitari
RECRUITING
Sabadell
Hospital Universitario Nuestra Senora de Candelaria
RECRUITING
Santa Cruz De Tenerife
Hospital Universitari Sant Joan de Reus
RECRUITING
Tarragona
Hospital Universitario Alvaro Cunqueiro
RECRUITING
Vigo
Contact Information
Primary
Clinical Trials Administrator
clinicaltrials@regeneron.com
844-734-6643
Time Frame
Start Date: 2022-10-26
Estimated Completion Date: 2028-10-30
Participants
Target number of participants: 500
Treatments
Cohort 1
Cemiplimab monotherapy
Cohort 2
Cemiplimab in combination with platinum-based chemotherapy
Sponsors
Leads: Regeneron Pharmaceuticals

This content was sourced from clinicaltrials.gov

Similar Clinical Trials